Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion.
Hamilos MI, Ostojic M, Beleslin B, Sagic D, Mangovski L, Stojkovic S, Nedeljkovic M, Orlic D, Milosavljevic B, Topic D, Karanovic N, Wijns W; NOBORI CORE Investigators. Hamilos MI, et al. Among authors: sagic d. J Am Coll Cardiol. 2008 Jun 3;51(22):2123-9. doi: 10.1016/j.jacc.2007.12.059. J Am Coll Cardiol. 2008. PMID: 18510958 Free article. Clinical Trial.
The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: the NOBORI PK study.
Ostojic M, Sagic D, Jung R, Zhang YL, Nedeljkovic M, Mangovski L, Stojkovic S, Debeljacki D, Colic M, Beleslin B, Milosavljevic B, Orlic D, Topic D, Karanovic N, Paunovic D, Christians U; NOBORI PK Investigators. Ostojic M, et al. Among authors: sagic d. Catheter Cardiovasc Interv. 2008 Dec 1;72(7):901-8. doi: 10.1002/ccd.21775. Catheter Cardiovasc Interv. 2008. PMID: 19016466 Free PMC article. Clinical Trial.
First clinical comparison of Nobori -Biolimus A9 eluting stents with Cypher- Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomes.
Ostojic M, Sagic D, Beleslin B, Jung R, Perisic Z, Jagic N, Nedeljkovic M, Mangovski L, Milosavljevic B, Stojkovic S, Orlic D, Antonic Z, Miloradovic V, Topic D, Paunovic D. Ostojic M, et al. Among authors: sagic d. EuroIntervention. 2008 Mar;3(5):574-9. doi: 10.4244/eijv3i5a103. EuroIntervention. 2008. PMID: 19608483
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study.
Danzi GB, Chevalier B, Urban P, Fath-Ordoubadi F, Carrie D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez JG, Sagic D, Laanmets P, Strupp G, West N, Paunovic D; NOBORI 2 Investigators. Danzi GB, et al. Among authors: sagic d. EuroIntervention. 2012 May 15;8(1):109-16. doi: 10.4244/EIJV8I1A17. EuroIntervention. 2012. PMID: 22278136 Free article.
Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.
Danzi GB, Piccolo R, Chevalier B, Urban P, Fath-Ordoubadi F, Carrie D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Goicolea Ruigomez J, Sagic D, Laanmets P, Strupp G, West N; Nobori 2 Investigators. Danzi GB, et al. Among authors: sagic d. Heart. 2017 Jan 15;103(2):111-116. doi: 10.1136/heartjnl-2016-309283. Epub 2016 Aug 10. Heart. 2017. PMID: 27511446
Outcomes and regional differences in practice in a worldwide coronary stent registry.
Cimci M, Polad J, Mamas M, Iniguez-Romo A, Chevalier B, Abhaichand R, Aminian A, Roguin A, Maluenda G, Angioi M, Cassel G, Kuramitsu S, Jacobs L, Debrus R, Malik F, Hildick-Smith D, Laanmets P, Roffi M; e-ULTIMASTER investigators. Cimci M, et al. Heart. 2022 Jul 27;108(16):1310-1318. doi: 10.1136/heartjnl-2021-320116. Heart. 2022. PMID: 35012960 Free PMC article.
92 results